Drug search by name
Glatiramer Subcutaneous and Kisqali
Determining the interaction of Glatiramer Subcutaneous and Kisqali and the possibility of their joint administration.
Check result:
Glatiramer Subcutaneous <> Kisqali
Relevance: 28.07.2022
Reviewer: Shkutko P.M., M.D., in
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Glatiramer Subcutaneous
Generic Name: glatiramer
Brand name: Copaxone, Glatopa
Synonyms: Glatiramer (injection), Glatiramer Acetate
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
The list of popular interactions
- Glatiramer Subcutaneous-Kisqali (200 MG Dose)
- Glatiramer Subcutaneous-Kisqali (400 MG Dose)
- Glatiramer Subcutaneous-Kisqali (600 MG Dose)
- Glatiramer Subcutaneous-Kisqali Femara Co-Pack
- Glatiramer Subcutaneous-Kisqali Femara Co-Pack 200 mg-2.5 mg Dose
- Glatiramer Subcutaneous-Kisqali Femara Co-Pack 400 mg-2.5 mg Dose
- Kisqali-Glatopa
- Kisqali-Glatopa injection
- Kisqali-Glecaprevir and pibrentasvir
- Kisqali-Gleevec
- Kisqali-Glenmax PEB DM
- Kisqali-Glenmax PEB DM FORTE
Doktika World
Interaction with food and lifestyle
Disease interaction